Transaminases increase: A manifestation of Duchenne's muscular dystrophy Aumento de transaminasas: Una manifestación de distrofia muscular de Duchenne
Author
dc.contributor.author
Avaria, María de los Ángeles
Author
dc.contributor.author
Beytía, María de los Ángeles
Author
dc.contributor.author
Kleinsteuber, Karin
Author
dc.contributor.author
Rodillo, Eliana
Author
dc.contributor.author
Alegría, Sylvia
Admission date
dc.date.accessioned
2019-03-11T13:19:29Z
Available date
dc.date.available
2019-03-11T13:19:29Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Revista Chilena de Pediatria, Volumen 83, Issue 3, 2018, Pages 258-261
Identifier
dc.identifier.issn
03704106
Identifier
dc.identifier.issn
07176228
Identifier
dc.identifier.other
10.4067/S0370-41062012000300007
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165627
Abstract
dc.description.abstract
Commonly used in clinical practice, glutamic oxalacetic (GOT) and glutamic piruvic (GPT) transaminases are produced in various body tissues, including striated muscle, so their blood elevation is not due exclusively to liver disease. The objective of this study is to demonstrate the correlation between elevated creatinkinase (CK) and transaminases in patients with diagnosis of Duchenne muscular dystrophy (DMD), the most frequent neuromuscular disease in children. Patients and Method: Assessment in 61 children with diagnosis of DMD of CK, AST and ALT levels, and their correlation. Results: All patients had increase of CK (x̄ = 13.363 IU/L), AST (x̄ = 203 IU/L) and ALT (x̄ = 194 IU/L) above normal values. The increase of transaminases related directly with the increase of CK. Conclusion: Patients with DMD have increased transaminases, so it is necessary to include this diagnostic possibility in a child with hypertransaminemia, prior to performing liver biopsy.